The measurement of nitric oxide in lipopolysaccharide (LPS)-stimulated RAW 264.7 cells is used as a model for evaluating the anti-inflammatory or chemopreventive potential of substances. Thienodolin, isolated from a Streptomyces sp. derived from Chilean marine sediment, inhibited nitric oxide production in LPS-stimulated RAW 264.7 cells (IC50 = 17.2 ± 1.2 ± μM). At both the mRNA and protein levels, inducible nitric oxide synthase (iNOS) was suppressed in a dose-dependent manner. Mitogen-activated protein kinases (MAPKs), one major upstream signaling pathway involved in the transcription of iNOS, were not affected by treatment of thienodolin. However, the compound blocked the degradation of IκBα resulting in inhibition of NF-κB p65 nuclear translocation, and inhibited the phosphorylation of signal transducers and activators of transcription 1 (STAT1) at Tyr701. This study supports further exploration of thienodolin as a potential therapeutic agent with a unique mechanistic activity.
CITATION STYLE
Park, E. J., Pezzuto, J. M., Jang, K. H., Nam, S. J., Bucarey, S. A., & Fenical, W. (2012). Suppression of nitric oxide synthase by thienodolin in lipopolysaccharide- stimulated RAW 264.7 murine macrophage cells. Natural Product Communications, 7(6), 789–794. https://doi.org/10.1177/1934578x1200700625
Mendeley helps you to discover research relevant for your work.